Sudeep Pharma reported a steady Q3 FY26 performance with 20% growth in the domestic market and strong traction in APAC and Europe. The company is strategically pivoting towards high-margin specialty ingredients and battery-grade iron phosphate, positioning itself as a key ex-China supplier. Significant capacity expansions are underway, including the 51,200 MTPA Nandesari facility due in March 2026 and the 25,000 MTPA Dahej battery materials plant slated for 2027. Management highlighted deepening relationships with global FMCG and baked goods leaders, providing long-term revenue visibility.

Sudeep Pharma reported a robust Q3 FY26 with total income rising 52% YoY to ₹179.2 crore, driven by strong demand in specialty ingredients and pharma segments. Profit After Tax (PAT) surged 66% YoY to ₹47.7 crore, supported by healthy EBITDA margins of 37.3%. A major strategic highlight is the company's entry into the EV battery materials space with a new 25,000 MT plant in Dahej and the commencement of early commercial orders. The company is also on track to commission its Nandesari greenfield facility by Q4 FY26, further boosting capacity.

Sudeep Pharma reported a strong performance for Q3 FY26, with standalone net profit growing 30.2% year-on-year to ₹26.87 crore. Revenue from operations saw a steady increase of 8.1% to ₹90.28 crore, while total income was bolstered by a significant rise in other income to ₹9.44 crore. For the nine-month period ended December 2025, the company achieved a profit of ₹81.82 crore, a 30.7% increase compared to the previous year. The company, which listed in November 2025, still holds ₹75.81 crore of unutilized IPO proceeds in term deposits intended for future capital expenditure.

Sudeep Pharma Limited reported a strong performance for the quarter ended December 31, 2025, with Profit After Tax (PAT) rising 30.2% YoY to ₹26.87 crore. Revenue from operations grew by 8.1% YoY to ₹90.28 crore, while 9-month PAT reached ₹81.82 crore compared to ₹62.61 crore in the previous year. The company, which listed in November 2025, still holds ₹75.81 crore of its IPO proceeds in term deposits pending deployment for capital expenditure. Additionally, the board has appointed Sharp & Tannan Associate as the internal auditor for FY 2026-27.

Sudeep Pharma's wholly-owned subsidiary, Sudeep Advanced Materials Private Limited, has acquired leasehold land rights in GIDC Dahej, Gujarat, for ₹20.97 crore. The land, measuring approximately 80,980 square meters, was purchased from DCM Shriram Fine Chemicals Limited. This strategic acquisition is intended for setting up a commercial manufacturing facility for Battery Grade Precursor Materials, specifically Iron Phosphate. This move marks a significant expansion into the high-growth electric vehicle and energy storage supply chain.

Sudeep Pharma conducted its maiden earnings call post-listing, highlighting a robust 32% CAGR in its specialty ingredients vertical since 2021, which now accounts for 40% of total revenue. The company is on track to commission its fifth and largest manufacturing facility in Nandesari by Q4 FY26 to address rising demand in regulated pharma and infant nutrition markets. Management clarified that 50% of its US business is exempt from recent tariffs, with customers absorbing the remaining impact, ensuring no significant volume loss. The strategic 85% acquisition of Ireland-based NSS in May 2025 further strengthens its global footprint in the high-barrier infant and medical nutrition segments.

Sudeep Pharma, which listed on BSE/NSE in November 2025, reported robust FY25 financials with a PAT of ₹139 crore and a high ROE of 28.1%. The company is undergoing a major capacity expansion, adding 51,200 MT to its existing 72,246 MT capacity, with commissioning expected by Q4FY26. It maintains a strong global presence across 100 countries, serving 1,100+ customers including 14 Fortune 500 companies. Additionally, the company is diversifying into high-growth battery materials, specifically iron phosphate for LFP batteries.

Sudeep Pharma Limited has entered into a loan agreement to provide an unsecured loan of INR 40 Crore to its wholly-owned subsidiary, Sudeep Advanced Materials Private Limited. The funds are specifically earmarked for working capital and the acquisition of industrial land in Dahej, Gujarat, to establish a commercial manufacturing facility for battery-grade precursor materials, primarily Iron Phosphate. The loan carries an interest rate of 8.5% per annum and is repayable on demand within a maximum period of five years. This move highlights the company's strategic push into the high-growth battery materials and EV supply chain sector.